These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 40299

  • 1. [Improvement of tardive dyskinesia with high doses of propranolol].
    Moreira MJ, Karniol IG.
    Rev Paul Med; 1979; 93(3-4):76-8. PubMed ID: 40299
    [No Abstract] [Full Text] [Related]

  • 2. Propranolol, anxiety, and tardive dyskinesia.
    Bacher NA, Lewis HA.
    J Clin Psychiatry; 1983 May; 44(5):196. PubMed ID: 6133849
    [No Abstract] [Full Text] [Related]

  • 3. Propranolol in the treatment of tardive dyskinesia.
    Perényi A, Farkas A.
    Biol Psychiatry; 1983 Mar; 18(3):391-4. PubMed ID: 6132627
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of tardive dyskinesia with propranolol.
    Schrodt GR, Wright JH, Simpson R, Moore DP, Chase S.
    J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534
    [Abstract] [Full Text] [Related]

  • 5. A case of tardive tremor successfully treated with clozapine.
    Delecluse F, Elosegi JA, Gérard JM.
    Mov Disord; 1998 Sep; 13(5):846-7. PubMed ID: 9756158
    [No Abstract] [Full Text] [Related]

  • 6. Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics.
    Kulik FA, Wilbur R.
    Psychopharmacol Bull; 1980 Jul; 16(3):18-9. PubMed ID: 6105690
    [No Abstract] [Full Text] [Related]

  • 7. Low-dose propranolol in tardive dyskinesia.
    Bacher NM, Lewis HA.
    Am J Psychiatry; 1980 Apr; 137(4):495-7. PubMed ID: 6102439
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC, Bai YM, Chen JY, Wang YC, Liou YJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):599-600. PubMed ID: 17920744
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stable remission of tardive dyskinesia by L-dopa.
    Ludatscher JI.
    J Clin Psychopharmacol; 1989 Feb 15; 9(1):39-41. PubMed ID: 2565346
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Tardive dyskinesia: etiology, clinical features and therapy].
    Furer V, Lichtenberg P, Heresco-Levy U.
    Harefuah; 2001 Mar 15; 140(3):248-52. PubMed ID: 11303354
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.